VALERIE GONZALES: Open Payments
NPI 1528663754 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 56 payments from 18 companies in 2025. Trend: 2023 $66 · 2024 $666 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 13 | $308 |
| Gilead Sciences, Inc. | 12 | $297 |
| Merck Sharp & Dohme LLC | 6 | $174 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Lilly USA, LLC | 3 | $66 |
| Amgen Inc. | 3 | $65 |
| Antares Pharma, Inc. | 3 | $58 |
| Napo Pharmaceuticals Inc | 2 | $49 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 1 | $26 |
Products named: PIFELTRO, APRETUDE, CABENUVA, MOUNJARO, DOVATO, XYOSTED, Mytesi, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
